We are live on ! Find out more
MLAB icon

Mesa Laboratories

151 hedge funds and large institutions have $1.01B invested in Mesa Laboratories in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 49 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

18% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 49

7% more capital invested

Capital invested by funds: $945M → $1.01B (+$63.7M)

5% more funds holding

Funds holding: 144151 (+7)

1.26% more ownership

Funds ownership: 91.22%92.48% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
151
Holders Change
+7
Holders Change %
+4.86%
% of All Funds
2.98%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
58
Reduced
49
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WA
26
Wasatch Advisors
Utah
$6.58M
Wellington Management Group
27
Wellington Management Group
Massachusetts
$6.32M -$52K -222 -0.9%
Invesco
28
Invesco
Georgia
$6.21M -$1.51M -6,434 -21%
Charles Schwab
29
Charles Schwab
California
$6.16M +$192K +818 +3%
Man Group
30
Man Group
United Kingdom
$5.61M +$311K +1,328 +6%
Comerica Bank
31
Comerica Bank
Texas
$5.4M -$49.2K -210 -1%
Luther King Capital Management (LKCM)
32
Luther King Capital Management (LKCM)
Texas
$5.38M -$2.56M -10,940 -34%
Marshall Wace
33
Marshall Wace
United Kingdom
$5.13M -$6.55M -27,964 -58%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$5.09M +$630K +2,689 +15%
MAM
35
Martingale Asset Management
Massachusetts
$4.89M +$211K +900 +5%
Morgan Stanley
36
Morgan Stanley
New York
$4.87M +$458K +1,957 +11%
Bank of America
37
Bank of America
North Carolina
$4.17M +$65.8K +281 +2%
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$3.9M +$451K +1,926 +14%
RJFSA
39
Raymond James Financial Services Advisors
Florida
$3.82M -$45.7K -195 -1%
TA
40
Teton Advisors
New York
$3.74M -$937K -4,000 -21%
BG
41
Bahl & Gaynor
Ohio
$3.37M +$14.1K +60 +0.4%
AllianceBernstein
42
AllianceBernstein
Tennessee
$3.04M -$911K -3,890 -24%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$2.99M +$174K +742 +7%
Legal & General Group
44
Legal & General Group
United Kingdom
$2.64M +$187K +797 +8%
Bessemer Group
45
Bessemer Group
New Jersey
$2.62M +$93.7K +400 +4%
Wells Fargo
46
Wells Fargo
California
$2.62M -$24.1K -103 -1%
UBS Group
47
UBS Group
Switzerland
$2.44M +$361K +1,541 +19%
Goldman Sachs
48
Goldman Sachs
New York
$2.3M -$8.41M -35,899 -80%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$2.25M -$262K -1,117 -11%
Public Sector Pension Investment Board (PSP Investments)
50
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.24M -$281K -1,200 -12%

MLAB Hedge Fund Activity: Q4 2019 in Review

151 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2019, worth a combined $1.01B — up 6.7% from $945M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MLAB positions and 7 closed out — a net gain of 12 holders — while 58 added to existing stakes and 49 trimmed.

The largest buyer was BlackRock, adding an estimated $8.24M. The largest seller was Goldman Sachs, cutting an estimated $8.41M.

  • 151 institutional investors held Mesa Laboratories (MLAB) as of Q4 2019, up from 144 in Q3 2019.
  • Funds reported $1.01B of Mesa Laboratories stock for Q4 2019, up 6.7% quarter-over-quarter.
  • 19 funds opened new Mesa Laboratories positions in Q4 2019 and 7 closed out, a net change of +12 holders.
  • The largest Mesa Laboratories buyer in Q4 2019 was BlackRock, an estimated $8.24M added.
  • The largest Mesa Laboratories seller in Q4 2019 was Goldman Sachs, an estimated $8.41M sold.

Based on aggregated 13F filings for Q4 2019.